市場調査レポート
商品コード
1211022
心臓閉鎖デバイスの世界市場規模調査・予測:閉鎖タイプ別(CHD閉鎖、PFO閉鎖、LAA閉鎖)、地域別分析、2022-2029年Global Heart Closure Devices Market Size study & Forecast, by Closure Type (Congenital Heart Defect Closure, PFO Closure, LAA Closure) and Regional Analysis, 2022-2029 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
心臓閉鎖デバイスの世界市場規模調査・予測:閉鎖タイプ別(CHD閉鎖、PFO閉鎖、LAA閉鎖)、地域別分析、2022-2029年 |
出版日: 2023年01月25日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界の心臓閉鎖装置市場は、2021年に約20億5,000万米ドルと評価され、予測期間2022-2029年には14.9%以上の健全な成長率で成長すると予測されています。
心臓閉鎖器具は、心室中隔欠損、心房中隔欠損、左心房付属器欠損、動脈管開存などの先天性心臓疾患の診断と治療のために特別に設計された医療器具の一種です。これらの病気は心臓の構造に影響を与え、その結果、心臓が血液を正常に送り出す能力を低下させます。先天性心疾患は、閉鎖器具を用いて心臓の右側と左側の隙間を塞ぐことで治療されます。このデバイスを取り巻く強力な臨床的証拠、高価格技術の採用の増加、償還の選択肢の拡大、MRI手術の採用の増加などの要因が、世界中で市場の成長に寄与しています。
先天性心疾患(CHD)の人口比率が上昇していることは、世界市場における心臓閉鎖装置の需要に直接的に関連しています。Indian Pediatrics誌によると、世界では毎年約135万人の赤ちゃんがCHDを患って生まれているとのことです。同様に、米国疾病対策予防センター(The Centers for Disease Control and Prevention)によると、米国では毎年約1%、約4万人の出生児がCHDの影響を受けていると推定されています。また、CHDを持つ赤ちゃんの約4人に1人が、生後1年以内に手術などを必要とする重症CHDであると言われています。したがって、このような高い疾病負担が世界市場の成長を規定することになります。さらに、病院や手術センターの数の増加、主要企業による革新的な製品の開発の高まりは、予測期間中にさまざまな有利な機会をもたらしています。しかし、高度に熟練した専門家の不足と厳しい規制の枠組みが、2022年から2029年の予測期間を通じて市場成長の妨げとなっています。
世界の心臓閉鎖装置市場の調査において考慮された主要地域は、アジア太平洋、北米、欧州、中南米、および世界のその他の地域です。北米は、臨床試験数の増加、政府のイニシアティブの高まり、高い研究開発投資によって、収益面で市場を独占しています。一方、アジア太平洋地域は、より強力なヘルスケアインフラの構築、人口の増加、対象疾患の有病率の上昇などの要因から、予測期間中に最も高いCAGRで成長すると予想されます。
本調査の目的は、近年における様々なセグメントおよび国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
Global Heart Closure Devices Market is valued at approximately USD 2.05 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.9% over the forecast period 2022-2029. Heart closure devices is a type of medical device that is specially designed for the diagnosis and treatment of congenital heart defects such as ventricular septal defect, atrial septal defect, left atrial appendage defect, and patent ductus arteriosus. These illnesses affect the heart structure, which results in reducing the heart's ability to pump blood normally. Congenital heart abnormalities are treated by using closure devices to seal a gap between the right and left sides of the heart. Factors such as strong clinical evidence surrounding the device, the rising adoption of high-priced technologies expanded options for reimbursement, and the increase in adoption of MRI procedures are contributing to the market growth around the world.
The rising incidences of congenital heart disease (CHD) among the population are directly associated with the demand for heart closure devices in the global market. The Indian Pediatrics reported that almost 1.35 million babies are born with CHD each year globally. Likewise, according to The Centers for Disease Control and Prevention, it was estimated that CHD affected approximately 1% or nearly 40,000 births per year in the United States. Also, around 1 in 4 babies with a CHD have a critical CHD, which requires surgery or other procedures in their first year of life. Therefore, the high disease burden is stipulating the growth of the global market. Moreover, the increasing number of hospitals & surgical centers, as well as the rising development of innovative products by key players are presenting various lucrative opportunities over the forecasting years. However, the shortage of highly skilled professionals and stringent regulatory frameworks are hampering the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Heart Closure Devices Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing number of clinical trials, along with the rising government initiatives and high R&D investments. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the rising development of stronger healthcare infrastructure, increasing population, as well as rising prevalence of target disease in the market space.
Major market players included in this report are:
Abbott
W. L. Gore & Associates, Inc.
Boston Scientific Corp.
Occlutech
Heartstitch
SMT
Cardia, Inc.
Lifetech Scientific Corp.
Lepu Medical Technology (Beijing)Co., Ltd.
AtriCure Inc.
Recent Developments in the Market:
Global Heart Closure Devices Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Closure Type, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Closure Type:
Congenital Heart Defect Closure
PFO Closure
LAA Closure
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World